Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update

Go back to Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update
(NASDAQ: MIRM) Delayed: 99.83 +0.30 (0.30%)
Previous Close $99.53    52 Week High
Open $98.02    52 Week Low
Day High $101.50    P/E N/A 
Day Low $97.01    EPS
Volume 92,514